Rolf I Skotheim

Summary

Affiliation: Institute for Cancer Research
Country: Norway

Publications

  1. ncbi Systematic bioinformatic analysis of expression levels of 17,330 human genes across 9,783 samples from 175 types of healthy and pathological tissues
    Sami Kilpinen
    Medical Biotechnology, VTT Technical Research Centre and University of Turku, Itäinen Pitkäkatu 4C, Turku, Finland
    Genome Biol 9:R139. 2008
  2. ncbi A universal assay for detection of oncogenic fusion transcripts by oligo microarray analysis
    Rolf I Skotheim
    Department of Cancer Prevention, Institute for Cancer Research, Norwegian Radium Hospital, Rikshospitalet University Hospital, Oslo, Norway
    Mol Cancer 8:5. 2009
  3. ncbi Transcriptome instability in colorectal cancer identified by exon microarray analyses: Associations with splicing factor expression levels and patient survival
    Anita Sveen
    Department of Cancer Prevention, Institute for Cancer Research, The Norwegian Radium Hospital, Oslo University Hospital, PO Box 4953 Nydalen, NO 0424 Oslo, Norway
    Genome Med 3:32. 2011
  4. ncbi Differentiation of human embryonal carcinomas in vitro and in vivo reveals expression profiles relevant to normal development
    Rolf I Skotheim
    Department of Genetics, Institute for Cancer Research, The Norwegian Radium Hospital and University of Oslo, Norway
    Cancer Res 65:5588-98. 2005
  5. ncbi Novel genomic aberrations in testicular germ cell tumors by array-CGH, and associated gene expression changes
    Rolf I Skotheim
    Department of Cancer Prevention, Institute for Cancer Research, Rikshospitalet Radiumhospitalet Medical Center, Oslo, Norway
    Cell Oncol 28:315-26. 2006
  6. ncbi Gene methylation profiles of normal mucosa, and benign and malignant colorectal tumors identify early onset markers
    Terje Ahlquist
    Department of Cancer Prevention, Institute for Cancer Research, Norwegian Radium Hospital, Rikshospitalet University Hospital, Oslo, Norway
    Mol Cancer 7:94. 2008
  7. ncbi The loss of NKX3.1 expression in testicular--and prostate--cancers is not caused by promoter hypermethylation
    Guro E Lind
    Department of Genetics, Institute for Cancer Research, The Norwegian Radium Hospital, 0310 Oslo, Norway
    Mol Cancer 4:8. 2005
  8. ncbi Genomic changes in chromosomes 10, 16, and X in malignant peripheral nerve sheath tumors identify a high-risk patient group
    Helge R Brekke
    Department of Cancer Prevention, Institute for Cancer Research, The Norwegian Radium Hospital, Rikshospitalet, Oslo University Hospital, Oslo, Norway
    J Clin Oncol 28:1573-82. 2010
  9. ncbi Array-CGH analysis of microdissected chromosome 19 markers in ovarian carcinoma identifies candidate target genes
    Francesca Micci
    Section for Cancer Cytogenetics, Institute for Medical Informatics, The Norwegian Radium Hospital, Oslo University Hospital, Montebello, Oslo, Norway
    Genes Chromosomes Cancer 49:1046-53. 2010
  10. ncbi Identification of an epigenetic biomarker panel with high sensitivity and specificity for colorectal cancer and adenomas
    Guro E Lind
    Department of Cancer Prevention, Institute for Cancer Research, Oslo University Hospital Radiumhospitalet, Oslo, Norway
    Mol Cancer 10:85. 2011

Collaborators

Detail Information

Publications36

  1. ncbi Systematic bioinformatic analysis of expression levels of 17,330 human genes across 9,783 samples from 175 types of healthy and pathological tissues
    Sami Kilpinen
    Medical Biotechnology, VTT Technical Research Centre and University of Turku, Itäinen Pitkäkatu 4C, Turku, Finland
    Genome Biol 9:R139. 2008
    ..This database of gene expression patterns in normal human tissues and pathological conditions covers 113 million datapoints and is available from the GeneSapiens website...
  2. ncbi A universal assay for detection of oncogenic fusion transcripts by oligo microarray analysis
    Rolf I Skotheim
    Department of Cancer Prevention, Institute for Cancer Research, Norwegian Radium Hospital, Rikshospitalet University Hospital, Oslo, Norway
    Mol Cancer 8:5. 2009
    ..However, the available methodologies to detect such fusions all have their distinct short-comings...
  3. ncbi Transcriptome instability in colorectal cancer identified by exon microarray analyses: Associations with splicing factor expression levels and patient survival
    Anita Sveen
    Department of Cancer Prevention, Institute for Cancer Research, The Norwegian Radium Hospital, Oslo University Hospital, PO Box 4953 Nydalen, NO 0424 Oslo, Norway
    Genome Med 3:32. 2011
    ..In the present study we analyze genome-wide disruption of pre-mRNA splicing, and propose transcriptome instability as a characteristic that is analogous to genomic instability on the transcriptome level...
  4. ncbi Differentiation of human embryonal carcinomas in vitro and in vivo reveals expression profiles relevant to normal development
    Rolf I Skotheim
    Department of Genetics, Institute for Cancer Research, The Norwegian Radium Hospital and University of Oslo, Norway
    Cancer Res 65:5588-98. 2005
    ....
  5. ncbi Novel genomic aberrations in testicular germ cell tumors by array-CGH, and associated gene expression changes
    Rolf I Skotheim
    Department of Cancer Prevention, Institute for Cancer Research, Rikshospitalet Radiumhospitalet Medical Center, Oslo, Norway
    Cell Oncol 28:315-26. 2006
    ..Testicular germ cell tumors of adolescent and young adult men (TGCTs) generally have near triploid and complex karyotypes. The actual genes driving the tumorigenesis remain essentially to be identified...
  6. ncbi Gene methylation profiles of normal mucosa, and benign and malignant colorectal tumors identify early onset markers
    Terje Ahlquist
    Department of Cancer Prevention, Institute for Cancer Research, Norwegian Radium Hospital, Rikshospitalet University Hospital, Oslo, Norway
    Mol Cancer 7:94. 2008
    ..Possible CIMP tumors were identified by comparing the methylation profile with microsatellite instability (MSI), BRAF-, KRAS-, and TP53 mutation status...
  7. ncbi The loss of NKX3.1 expression in testicular--and prostate--cancers is not caused by promoter hypermethylation
    Guro E Lind
    Department of Genetics, Institute for Cancer Research, The Norwegian Radium Hospital, 0310 Oslo, Norway
    Mol Cancer 4:8. 2005
    ..However, other epigenetic mechanisms, such as modulation of chromatin structure or modifications of histones, may explain the lack of NKX3.1 expression, which is seen in most TGCTs and prostate cancer specimens...
  8. ncbi Genomic changes in chromosomes 10, 16, and X in malignant peripheral nerve sheath tumors identify a high-risk patient group
    Helge R Brekke
    Department of Cancer Prevention, Institute for Cancer Research, The Norwegian Radium Hospital, Rikshospitalet, Oslo University Hospital, Oslo, Norway
    J Clin Oncol 28:1573-82. 2010
    ..The purpose of this study was to identify genetic aberrations contributing to clinical aggressiveness of malignant peripheral nerve sheath tumors (MPNSTs)...
  9. ncbi Array-CGH analysis of microdissected chromosome 19 markers in ovarian carcinoma identifies candidate target genes
    Francesca Micci
    Section for Cancer Cytogenetics, Institute for Medical Informatics, The Norwegian Radium Hospital, Oslo University Hospital, Montebello, Oslo, Norway
    Genes Chromosomes Cancer 49:1046-53. 2010
    ....
  10. ncbi Identification of an epigenetic biomarker panel with high sensitivity and specificity for colorectal cancer and adenomas
    Guro E Lind
    Department of Cancer Prevention, Institute for Cancer Research, Oslo University Hospital Radiumhospitalet, Oslo, Norway
    Mol Cancer 10:85. 2011
    ..This study investigates a panel of epigenetic markers for the detection of colorectal cancer and adenomas...
  11. ncbi Topoisomerase-II alpha is upregulated in malignant peripheral nerve sheath tumors and associated with clinical outcome
    Rolf I Skotheim
    Department of Genetics, Institute for Cancer Research, The Norwegian Radium Hospital and University of Oslo, Norway
    J Clin Oncol 21:4586-91. 2003
    ..This study is the first to suggest that TOP2A expression may be a predictive factor for adverse outcome in MPNST...
  12. ncbi ColoGuideEx: a robust gene classifier specific for stage II colorectal cancer prognosis
    Trude H Agesen
    Department of Cancer Prevention, Institute for Cancer Research, The Norwegian Radium Hospital, Oslo University Hospital, Nydalen, Oslo, Norway
    Gut 61:1560-7. 2012
    ..The present study aimed to develop a gene expression classifier for improved risk stratification of patients with stage II CRC...
  13. ncbi Distinct high resolution genome profiles of early onset and late onset colorectal cancer integrated with gene expression data identify candidate susceptibility loci
    Marianne Berg
    Department of Cancer Prevention, Institute for Cancer Research, Oslo University Hospital, Norwegian Radium Hospital, Oslo, Norway
    Mol Cancer 9:100. 2010
    ..Integration analysis of CNV and genome wide mRNA expression data, available for the same tumors, was performed to identify a restricted candidate gene list...
  14. ncbi Phospholipase C isozymes are deregulated in colorectal cancer--insights gained from gene set enrichment analysis of the transcriptome
    Stine A Danielsen
    Department of Cancer Prevention, Institute for Cancer Research, Oslo University Hospital, Oslo, Norway
    PLoS ONE 6:e24419. 2011
    ..In conclusion, we have identified significantly deregulated pathways in CRC, and validated repression of PLCD1 and PLCE1 expression. This illustrates that the GSEA approach may guide discovery of novel biomarkers in cancer...
  15. ncbi Hypermethylated MAL gene - a silent marker of early colon tumorigenesis
    Guro E Lind
    Department of Cancer Prevention, Institute for Cancer Research, The Norwegian Radium Hospital, Rikshospitalet University Hospital, Oslo, Norway
    J Transl Med 6:13. 2008
    ..The aim of the present study was to investigate the potential of the MAL (T-cell differentiation protein) gene as an early epigenetic diagnostic marker for colorectal tumors...
  16. ncbi The exon-level biomarker SLC39A14 has organ-confined cancer-specificity in colorectal cancer
    Anita Sveen
    Department of Cancer Prevention, Institute for Cancer Research, The Norwegian Radium Hospital, Oslo University Hospital, Oslo, Norway
    Int J Cancer 131:1479-85. 2012
    ..In conclusion, the SLC39A14-exon4B transcript variant is a CRC biomarker with high sensitivity and organ-confined specificity. Further use of the transcript and its encoded protein isoform should be explored in an organ-confined context...
  17. ncbi Fusion gene microarray reveals cancer type-specificity among fusion genes
    Marthe Løvf
    Department of Cancer Prevention, Institute for Cancer Research, Norwegian Radium Hospital, Oslo University Hospital, Oslo, Norway
    Genes Chromosomes Cancer 50:348-57. 2011
    ..We therefore find it unlikely that the assayed fusion genes are commonly present across multiple cancer types...
  18. ncbi The epigenome of testicular germ cell tumors
    Guro E Lind
    Department of Cancer Prevention, Rikshospitalet Radiumhospitalet Medical Centre, Montebello and Centre for Cancer Biomedicine, University of Oslo, Oslo, Norway
    APMIS 115:1147-60. 2007
    ..Aberrant DNA methylation has the potential to improve current diagnostics by noninvasive testing and might also serve as a prognostic marker for treatment response...
  19. ncbi Candidate genes for testicular cancer evaluated by in situ protein expression analyses on tissue microarrays
    Rolf I Skotheim
    Department of Genetics, Institute for Cancer Research, The Norwegian Radium Hospital, Oslo, Norway
    Neoplasia 5:397-404. 2003
    ..In summary, we have developed a high-throughput tool for the evaluation of TGCT markers, and utilized this to validate five candidate genes whose protein expressions were indeed deregulated in TGCT...
  20. ncbi ColoGuidePro: a prognostic 7-gene expression signature for stage III colorectal cancer patients
    Anita Sveen
    Department of Cancer Prevention, Institute for Cancer Research, The Norwegian Radium Hospital, Oslo, Norway
    Clin Cancer Res 18:6001-10. 2012
    ..This study was conducted to develop a clinically feasible and robust prognostic classifier for these patients independent of adjuvant treatment...
  21. ncbi MiR-9, -31, and -182 deregulation promote proliferation and tumor cell survival in colon cancer
    Lina Cekaite
    Department of Cancer Prevention, Institute for Cancer Research, Norwegian Radium Hospital, Oslo University Hospital, Oslo, Norway
    Neoplasia 14:868-79. 2012
    ..This study suggests that deregulated expression of miR-9, miR-31, and miR-182 during carcinogenesis plays a significant role in the development of colon cancer by promoting proliferation and tumor cell survival...
  22. ncbi Gene expression profiles of primary colorectal carcinomas, liver metastases, and carcinomatoses
    Kristine Kleivi
    Department of Genetics, Institute for Cancer Research, Rikshospitalet Radiumhospitalet Medical Center, Oslo, Norway
    Mol Cancer 6:2. 2007
    ..Therefore, the aim of the present study is to investigate and compare the gene expression patterns of primary carcinomas (n = 18), liver metastases (n = 4), and carcinomatoses (n = 4), relative to normal samples from the large bowel...
  23. ncbi Identification of p53 as a strong predictor of survival for patients with malignant peripheral nerve sheath tumors
    Helge R Brekke
    Department of Cancer Prevention, Institute for Cancer Research, Norwegian Radium Hospital, Rikshospitalet University Hospital, Montebello, Oslo, Norway
    Neuro Oncol 11:514-28. 2009
    ..Patients in complete remission with a primary p53-positive MPNST diagnosis may be considered in a high-risk subgroup and candidates for adjuvant treatment...
  24. ncbi TPD52, a candidate gene from genomic studies, is overexpressed in testicular germ cell tumours
    Sharmini Alagaratnam
    Department of Cancer Prevention, Institute for Cancer Research, Norwegian Radium Hospital, Rikshospitalet HE, Oslo, Norway
    Mol Cell Endocrinol 306:75-80. 2009
    ..TPD52 was expressed in two-thirds of seminomas and embryonal carcinomas, and at intermediate frequencies in the more differentiated non-seminomas...
  25. ncbi FLI1 is a novel ETS transcription factor involved in gene fusions in prostate cancer
    Paula Paulo
    Department of Genetics, Portuguese Oncology Institute, Porto, Portugal
    Genes Chromosomes Cancer 51:240-9. 2012
    ..015). We report that FLI1 is a novel ETS transcription factor involved in gene fusions in prostate cancer and that intratumor genetic heterogeneity of ETS rearrangements can occasionally be found in index primary tumors...
  26. ncbi NKX3.1 expression is lost in testicular germ cell tumors
    Rolf I Skotheim
    Department of Genetics, Institute for Cancer Research, The Norwegian Radium Hospital and University of Oslo, Oslo, Norway
    Am J Pathol 163:2149-54. 2003
    ..These results suggest that NKX3.1 is essential for normal testis function and that its loss of expression is highly associated with the invasive phenotype of testicular germ cell tumors...
  27. ncbi Lack of parental origin specificity of altered alleles at 11p15 in testicular germ cell tumors
    Sigrid M Kraggerud
    Department of Genetics, Institute for Cancer Research, The Norwegian Radium Hospital, Montebello, N-0310, Oslo, Norway
    Cancer Genet Cytogenet 147:1-8. 2003
    ..In summary, our results support the theory that a nonimprinted 11p15 tumor suppressor gene is involved in the development of a subgroup of TGCTs...
  28. ncbi The testicular germ cell tumour genome
    Rolf I Skotheim
    Department of Genetics, Institute for Cancer Research, The Norwegian Radium Hospital, N-0310 Oslo, Norway
    APMIS 111:136-50; discussion 50-1. 2003
    ....
  29. ncbi Reverse painting of microdissected chromosome 19 markers in ovarian carcinoma identifies a complex rearrangement map
    Francesca Micci
    Department of Medical Genetics, The Norwegian Radium Hospital, Rikshospitalet University Hospital, Montebello, Oslo, Norway
    Genes Chromosomes Cancer 48:184-93. 2009
    ..A detailed map of the rearrangements should provide clues to the positions of oncogenes and potential fusion genes important in ovarian carcinogenesis...
  30. ncbi Survey of 548 oncogenic fusion transcripts in thyroid tumors supports the importance of the already established thyroid fusions genes
    Ricardo Celestino
    Department of Cancer Prevention, Institute for Cancer Research, Norwegian Radium Hospital, Oslo University Hospital, Oslo, Norway
    Genes Chromosomes Cancer 51:1154-64. 2012
    ..Our results reinforce the pathogenic role played by RET/PTC1, RET/PTC3, and PAX8-PPARG fusion genes in thyroid tumorigenesis...
  31. ncbi Whole-transcriptome sequencing identifies novel IRF2BP2-CDX1 fusion gene brought about by translocation t(1;5)(q42;q32) in mesenchymal chondrosarcoma
    Kaja B Nyquist
    Section for Cancer Cytogenetics, Institute for Medical Informatics, The Norwegian Radium Hospital, Oslo University Hospital, Oslo, Norway
    PLoS ONE 7:e49705. 2012
    ..This demonstrates that genetic heterogeneity exists in mesenchymal chondrosarcoma...
  32. ncbi Genome profiles of familial/bilateral and sporadic testicular germ cell tumors
    Sigrid Marie Kraggerud
    Department of Genetics, Institute for Cancer Research, The Norwegian Radium Hospital, Oslo, Norway
    Genes Chromosomes Cancer 34:168-74. 2002
    ..02, respectively), whereas gain of the proximal 17q (17q11.2-21) and high-level amplification from chromosome arm 12p, and losses from 10q were associated with nonseminomas (P < 0.001, P = 0.04, and P = 0.03, respectively)...
  33. ncbi A tumor-associated mutation of FYVE-CENT prevents its interaction with Beclin 1 and interferes with cytokinesis
    Antonia P Sagona
    Centre for Cancer Biomedicine, Faculty of Medicine, University of Oslo, Oslo, Norway
    PLoS ONE 6:e17086. 2011
    ..These findings suggest a positive feedback loop for recruitment of FYVE-CENT and Beclin 1 to the intercellular bridge during cytokinesis, and reveal a novel potential tumor suppressor mechanism for Beclin 1...
  34. ncbi Spindle proteins are differentially expressed in the various histological subtypes of testicular germ cell tumors
    Espen Burum-Auensen
    Division of Pathology, Medical Faculty, University of Oslo, Rikshospitalet, Oslo University Hospital, Oslo, Norway
    J Carcinog 9:1. 2010
    ..The importance of these spindle proteins remains unknown in the development of TGCTs, thus we have explored the expression levels of these proteins in normal and malignant testicular tissues...
  35. ncbi Alternative splicing in cancer: noise, functional, or systematic?
    Rolf I Skotheim
    Department of Cancer Prevention, Institute for Cancer Research, Rikshospitalet Radiumhospitalet Medical Center, Oslo, Norway
    Int J Biochem Cell Biol 39:1432-49. 2007
    ..These studies are expected to open an entirely new level of genetic information that is currently still poorly understood...
  36. ncbi New insights into testicular germ cell tumorigenesis from gene expression profiling
    Rolf I Skotheim
    Department of Genetics, Institute for Cancer Research, The Norwegian Radium Hospital, N 0310 Oslo, Norway
    Cancer Res 62:2359-64. 2002
    ....